Effects of Resistance Training Preconditioning on Skeletal Muscle Recovery From a Period of Disuse in Young Adults
NCT ID: NCT05760066
Last Updated: 2023-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
24 participants
INTERVENTIONAL
2023-08-01
2024-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* To determine if performing RT prior to a period of disuse enhances the regain of strength, skeletal muscle size, and skeletal muscle quality while performing RT after a period of disuse.
* To determine if performing RT prior to a period of disuse dampens the maladaptive effects of disuse on muscle size, muscle quality, and strength.
* To determine the anabolic and proteolytic mechanisms underpinning the observed outcomes.
Participants will:
1. Perform either 6 weeks of resistance training or maintain an untrained lifestyle
2. Perform 2 weeks of limb immobilization induced disuse of a randomized leg
3. Perform 6 weeks of resistance training
Researchers will compare the resistance training preconditioning condition vs the non-trained condition to see if resistance training prior to a period of disuse is beneficial during the disuse period and in the return to training period on skeletal muscle size, strength, and underpinning molecular markers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resistance Training, Detraining, and Retraining Study 2022
NCT05553769
Recovery Kinetics Following Eccentric Exercise
NCT04733911
Recovery Kinetics After Different Power Training Protocols (PTRecovery)
NCT04847427
Effects of Blood Flow Restriction During Eccentric Resistance Exercise
NCT05606744
Effects of Unloading on Muscle Mass
NCT00936039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Resistance Training Preconditioning (PRECON)
This group will perform:
1. 6 weeks of lower body focused resistance training
2. 2 weeks of locking brace-induced immobilization of a randomized leg
3. 6 weeks of lower body focused resistance training
Resistance Training Preconditioning
Resistance training prior to disuse-induced atrophy followed by another period of resistance training
Control (CTL)
This group will perform:
1. 6 weeks of activities of daily living (no training)
2. 2 weeks of locking brace-induced immobilization of a randomized leg
3. 6 weeks of lower body focused resistance training
Control
Activities of daily living prior to disuse-induced atrophy followed by a period of resistance training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resistance Training Preconditioning
Resistance training prior to disuse-induced atrophy followed by another period of resistance training
Control
Activities of daily living prior to disuse-induced atrophy followed by a period of resistance training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Free from medical implants in lower extremity that would interfere with low-dose radiation
* Are not allergic to ultrasound gel or Lidocaine
* Have no or minimal experience with resistance training (less than 1 training session/week for a 1 year period)
Exclusion Criteria
* Have known overt cardiovascular or metabolic disease
* Have a medical condition that would contraindicate participating in an exercise program or donating a skeletal muscle biopsy (e.g. blood clotting disorder, taking blood thinners, etc.)
* Are undergoing medical treatment for a disease that would interfere physiologically or logistically with study outcomes and/or protocols (e.g. undergoing chemotherapy and/or radiation for cancer treatment)
* Have consumed supplemental protein, creatine, and/or agents that affect hormone status (e.g. testosterone, growth hormone boosters, etc.) within the previous 2 months.
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Auburn University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Roberts
Professor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MDR0823
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.